Related Experiment Video
Updated: Aug 1, 2025
Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice
Published on: January 2, 2013
Pathogenesis of Cerebral Malaria: New Trends and Insights for Developing Adjunctive Therapies
Praveen Kishore Sahu1,2, Sanjib Mohanty1,2
1Department of Molecular Biology & Infectious Diseases, Community Welfare Society Hospital, Rourkela 769042, Odisha, India.
Abstract:
No specific or adjunctive therapies exist to treat cerebral malaria (CM) as of date. CM is a neuropathological manifestation of the malaria infection in humans, caused by the hemoparasitic pathogen Plasmodium falciparum. Driven through a multitude of virulence factors, varied immune responses, variations in brain swelling with regard to the age of patients, parasite biomass, and parasite-typing, the essential pathogenetic mechanisms underlying clinical CM have remained elusive. However, a recent series of studies based on molecular, immunologic, and advanced neuroradiologic and machine-learning approaches have unraveled new trends and insights to better understand and focus on the key determinants of CM in humans. This could possibly be the beginning of the design of new and effective adjunctive therapies that may not be common or applicable to the entire malarious world, but that could, rather, be specific to the variations in the determinants of CM.
Insights
Cerebral malaria (CM) lacks specific treatments. Recent research using advanced methods is revealing key factors driving CM, paving the way for targeted therapies.
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- Cerebral malaria (CM), a severe manifestation of Plasmodium falciparum infection, currently has no specific or adjunctive treatments.
- The complex pathogenesis of CM is driven by virulence factors, immune responses, and patient-specific variables like age and parasite factors, making it difficult to understand.
Purpose of the Study:
- To explore recent advancements in understanding the key determinants of cerebral malaria.
- To identify potential avenues for developing targeted adjunctive therapies for CM.
Main Methods:
- Review of molecular, immunologic, and advanced neuroradiologic studies.
- Application of machine-learning approaches to analyze CM data.
Main Results:
- New insights into the complex pathogenetic mechanisms of CM have been uncovered.
- Identification of key determinants influencing CM variations in patients.
Conclusions:
- Emerging research provides a foundation for designing novel, specific adjunctive therapies for cerebral malaria.
- Future therapies may be tailored to individual patient and parasite variations rather than a one-size-fits-all approach.
More Related Videos
09:04In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
Published on: June 8, 2017
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024